News
HOLX
71.65
+1.26%
0.89
Earnings Not Telling The Story For Hologic, Inc. (NASDAQ:HOLX)
Simply Wall St · 20h ago
Positive Outlook for Hologic Amidst Revenue and EPS Adjustments: Analyst Recommends Buy
TipRanks · 2d ago
Hologic Price Target Maintained With a $90.00/Share by Needham
Dow Jones · 3d ago
Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Benzinga · 3d ago
Hologic recalls BioZorb Marker over safety concerns
Seeking Alpha · 4d ago
Peering Into Hologic's Recent Short Interest
Benzinga · 4d ago
FDA: IDENTIFIED HOLOGIC'S RECALL AS MOST SERIOUS TYPE; RECALL INVOLVES REMOVING DEVICES FROM WHERE THEY ARE USED/SOLD
Reuters · 4d ago
FDA: HOLOGIC REMOVES BIOZORB 3D BIOABSORBABLE MARKERS DUE TO RISK FOR PATIENT COMPLICATIONS
Reuters · 4d ago
FDA: THERE HAVE BEEN 252 REPORTED INJURIES RELATED TO HOLOGIC'S BIOZORB 3D BIOABSORBABLE MARKERS
Reuters · 4d ago
Hologic enters agreement with CDC to develop ASRs
TipRanks · 4d ago
HOLOGIC TO CONTRIBUTE TO H5N1 BIRD FLU TEST DEVELOPMENT VIA AGREEMENT ISSUED BY CDC
Reuters · 4d ago
Oversold Conditions For Hologic (HOLX)
NASDAQ · 6d ago
Hologic price target lowered to $84 from $90 at UBS
TipRanks · 6d ago
HOLOGIC INC <HOLX.O>: UBS CUTS TARGET PRICE TO $84 FROM $90
Reuters · 6d ago
Weekly Report: what happened at HOLX last week (1209-1213)?
Weekly Report · 12/16 09:20
Salesforce upgraded, ServiceNow downgraded: Wall Street’s top analyst calls
TipRanks · 12/13 14:40
Wolfe Research Initiates Coverage On Hologic with Peer Perform Rating
Benzinga · 12/13 14:15
Hologic initiated with a Peer Perform at Wolfe amid near-term headwinds
TipRanks · 12/13 11:50
Hologic initiated with a Peer Perform at Wolfe Research
TipRanks · 12/13 11:00
Hologic Trades at 17.62X P/E: Should You Buy, Sell or Hold the Stock?
NASDAQ · 12/11 12:55
More
Webull provides a variety of real-time HOLX stock news. You can receive the latest news about Hologic Inc through multiple platforms. This information may help you make smarter investment decisions.
About HOLX
Hologic, Inc. is a medical technology company focused on improving women's health and well-being through early detection and treatment. It is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products, which are used to aid in the screening and diagnosis of human diseases. Breast Health segment offers a portfolio of solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment. It also offers wireless breast surgery localization and lymphatic tracing solutions. GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.